Prolonged myelosuppression with clofarabine in the treatment of patients with relapsed or refractory, aggressive non-Hodgkin lymphoma

We evaluated the safety and efficacy of the purine nucleoside analogue, clofarabine, in patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) and mantle cell lymphoma (MCL). Six patients with DLBCL (n = 5) or MCL (n = 1) and a median age of 68 years were treated with 40 mg/m(2)...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: BLUM, KRISTIE A., HAMADANI, MEHDI, PHILLIPS, GARY S., LOZANSKI, GERARD, JOHNSON, AMY J., LUCAS, DAVID M., SMITH, LISA L., BAIOCCHI, ROBERT, LIN, THOMAS S., PORCU, PIERLUIGI, DEVINE, STEVEN M., BYRD, JOHN C.
Formato: Artigo
Idioma:Inglês
Publicado em: 2009
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3695225/
https://ncbi.nlm.nih.gov/pubmed/19263294
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/10428190902730227
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados